DOI:
10.1055/s-00032260
Digestive Disease Interventions
LinksClose Window
References
Rinke A, Wittenberg M, Schade-Brittinger C. PROMID Study Group. et al.
Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors (PROMID): results of long-term survival.
Neuroendocrinology 2017;
104 (01) 26-32
We do not assume any responsibility for the contents of the web pages of other providers.